(19)
(11) EP 3 761 962 A1

(12)

(43) Date of publication:
13.01.2021 Bulletin 2021/02

(21) Application number: 19764715.9

(22) Date of filing: 05.03.2019
(51) International Patent Classification (IPC): 
A61K 9/08(2006.01)
A61K 39/395(2006.01)
A61K 47/22(2006.01)
A61K 38/00(2006.01)
A61K 47/10(2017.01)
A61K 47/32(2006.01)
(86) International application number:
PCT/US2019/020751
(87) International publication number:
WO 2019/173338 (12.09.2019 Gazette 2019/37)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.03.2018 US 201862639950 P
01.06.2018 US 201862679647 P

(71) Applicant: Reform Biologics, LLC
Woburn, MA 01801 (US)

(72) Inventors:
  • SOANE, David, S.
    Palm Beach, FL 33480 (US)
  • WUTHRICH, Philip
    Watertown, MA 02472 (US)
  • MAHONEY, Robert, P.
    Newbury, MA 01922 (US)
  • NAIK, Subhashchandra
    Watertown, MA 02472 (US)
  • TRAN, Timothy
    Medford, MA 02155 (US)
  • PORTILLA, Rosa, Carado
    Middleton, MA 01949 (US)
  • GREENE, Daniel, G.
    Belmont, MA 02478 (US)

(74) Representative: Snaith, James Michael et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS